Editorial Notes
CodificationIn subsec. (d), “section 3324(a) and (span) of title 31 and section 6101 of title 41” substituted for “section 3648 and 3709 of the Revised Statutes (31 U.S.C. 529; 41 U.S.C. 5)” on authority of Puspan. L. 97–258, § 4(span), Sept. 13, 1982, 96 Stat. 1067, which Act enacted Title 31, Money and Finance, and Puspan. L. 111–350, § 6(c), Jan. 4, 2011, 124 Stat. 3854, which Act enacted Title 41, Public Contracts.
Amendments1978—Subsec. (e). Puspan. L. 95–626 inserted provisions authorizing appropriations for fiscal years ending Sept. 30, 1979, 1980, and 1981.
1977—Subsec. (e). Puspan. L. 95–83 substituted provisions authorizing appropriations for fiscal years ending Sept. 30, 1977 and 1978, for prior such authorization for fiscal year 1977.
Statutory Notes and Related Subsidiaries
Effective DateSection effective July 1, 1975, see section 608 of Puspan. L. 94–63, set out as an Effective Date of 1975 Amendment note under section 247span of this title.
Ricky Ray Hemophilia Relief FundPuspan. L. 105–369, Nov. 12, 1998, 112 Stat. 3368, as amended by Puspan. L. 106–554, § 1(a)(6) [title IX, § 932], Dec. 21, 2000, 114 Stat. 2763, 2763A–585, provided that:“SECTION 1. SHORT TITLE; TABLE OF CONTENTS.“(a)Short Title.—This Act may be cited as the ‘Ricky Ray Hemophilia Relief Fund Act of 1998’.
“(span)Table of Contents.— <span value="i" class="num">“title i—</span><span class="centered small-caps">hemophilia relief fund</span><section style="-uslm-lc:I580467;"><span value="101" class="num">“SEC. 101.</span><span> RICKY RAY HEMOPHILIA RELIEF FUND.</span><div class="subsection"><span value="a" class="num">“(a)</span><span><span class="inline">Establishment</span>.—</span><span>There is established in the Treasury of the United States a trust fund to be known as the ‘Ricky Ray Hemophilia Relief Fund’, which shall be administered by the Secretary of the Treasury.</span></div><div class="subsection"><span value="span" class="num">“(span)</span><span><span class="inline">Investment of Amounts in Fund</span>.—</span><span>Amounts in the Fund shall be invested in accordance with <span href="/us/usc/t31/s9702" class="ref">section 9702 of title 31</span>, United States Code, and any interest on and proceeds from any such investment shall be credited to and become part of the Fund.</span></div><div class="subsection"><span value="c" class="num">“(c)</span><span><span class="inline">Availability of Fund</span>.—</span><span>Amounts in the Fund shall be available only for disbursement by the Secretary of Health and Human Services under section 103.</span></div><div class="subsection"><span value="d" class="num">“(d)</span><span><span class="inline">Termination</span>.—</span><span>The Fund shall terminate upon the expiration of the 5-year period beginning on the date of the enactment of this Act [<span date="1998-11-12" class="date">Nov. 12, 1998</span>]. If all of the amounts in the Fund have not been expended by the end of the 5-year period, investments of amounts in the Fund shall be liquidated, the receipts of such liquidation shall be deposited in the Fund, and all funds remaining in the Fund shall be deposited in the miscellaneous receipts account in the Treasury of the United States.</span></div><div class="subsection"><span value="e" class="num">“(e)</span><span><span class="inline">Authorization of Appropriations</span>.—</span><span>There is authorized to be appropriated to the Fund to carry out this title $750,000,000. There is appropriated to the Fund $475,000,000 for fiscal year 2001, to remain available until expended.</span></div></section><section style="-uslm-lc:I580467;"><span value="102" class="num">“SEC. 102.</span><span> COMPASSIONATE PAYMENT RELATING TO INDIVIDUALS WITH BLOOD-CLOTTING DISORDERS AND HIV.</span><div class="subsection"><span value="a" class="num">“(a)</span><span><span class="inline">In General</span>.—</span><span>If the conditions described in subsection (span) are met and if there are sufficient amounts in the Fund to make each payment, the Secretary shall make a single payment of $100,000 from the Fund to any individual who has an HIV infection and who is described in one of the following paragraphs:</span><div class="paragraph"><span value="1" class="num">“(1)</span><span> The individual has any form of blood-clotting disorder, such as hemophilia, and was treated with antihemophilic factor at any time during the period beginning on <span date="1982-07-01" class="date">July 1, 1982</span>, and ending on <span date="1987-12-31" class="date">December 31, 1987</span>.</span></div><div class="paragraph"><span value="2" class="num">“(2)</span><span> The individual—</span><div class="subparagraph"><span value="A" class="num">“(A)</span><span> is the lawful spouse of an individual described in paragraph (1); or</span></div><div class="subparagraph"><span value="B" class="num">“(B)</span><span> is the former lawful spouse of an individual described in paragraph (1) and was the lawful spouse of the individual at any time after a date, within the period described in such subparagraph, on which the individual was treated as described in such paragraph and through medical documentation can assert reasonable certainty of transmission of HIV from individual described in paragraph (1).</span></div></div></div></section>
